Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis

OBJECTIVE: Children with Kawasaki disease (KD) and an initial echocardiogram that demonstrates coronary artery aneurysms (CAAs, Z score ≥2.5) are at high risk for severe cardiovascular complications. We sought to determine if primary adjunctive infliximab treatment at a dose of either 5 or 10 mg/kg,...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyata, Koichi, Bainto, Emelia V, Sun, Xiaoying, Jain, Sonia, Dummer, Kirsten B, Burns, Jane C, Tremoulet, Adriana H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511975/
https://www.ncbi.nlm.nih.gov/pubmed/37258054
http://dx.doi.org/10.1136/archdischild-2023-325639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511975/
https://www.ncbi.nlm.nih.gov/pubmed/37258054
http://dx.doi.org/10.1136/archdischild-2023-325639

Ejemplares similares